Insights On Drug Development

  1. Choosing The Right Ligand Binding Assay Platform For Drug Development 6/17/2026

    Choosing the wrong ligand binding assay platform early in drug development can cost you time, data quality, and regulatory standing. Learn what actually drives platform selection for biologics.

  2. Data-Driven Strategies To De-Risk OSD Development 6/17/2026

    Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk.

  3. How Adept Formulation Helps Overcome Manufacturability Challenges 6/17/2026

    Initial development, scaleup, and tech transfer of complex multi-particulate drug systems requires meticulous planning to mitigate manufacturing risks.

  4. ADCs As Biological Missiles For Targeted Therapies 6/15/2026

    Antibody-drug conjugates are reshaping cancer treatment. Learn how monoclonal antibody targeting, linker design, and next-gen payloads are defining the future of precision oncology.

  5. Solving Formulation Challenges Across Modalities 6/15/2026

    Optimize drug delivery by leveraging advanced nanoparticle engineering to dramatically increase small-molecule oral drug loading and enable ultra-high-concentration subcutaneous formulations.

  6. Batch Manufacturing Vs Continuous Manufacturing With Process Analytical Technology 6/15/2026

    Batch or continuous manufacturing? The answer depends heavily on how you use process analytical technology. Understand the tradeoffs before your next program decision.

  7. Coordinated Development As An Execution Framework 6/9/2026

    See how integrating clinical, development, manufacturing, and supply functions within a single execution framework can transform program performance and accelerate development success.

  8. Science With Purpose: Advancing Sustainability In Biopharma Testing 6/9/2026

    Learn how biopharma labs are cutting animal use, energy, and paper waste while maintaining GMP compliance — with specific data on 85% labor reductions and 1 ton of CO2e saved annually.

  9. Cracking Complexity: Learnings From 70+ Bispecific Antibody Programs 6/9/2026

    The goal is practical: help development teams make early decisions that balance speed, quality, and risk and support a smoother path to the clinic.

  10. Accelerating Antibody Development: A Proven Path From Gene To GMP 6/5/2026

    Discover how an optimized, end-to-end development strategy can help sponsors reach key clinical milestones faster and bring potentially life-saving therapies to patients sooner.